Professional Documents
Culture Documents
We Will Begin Momentarily at 2pm ET: Have Questions?
We Will Begin Momentarily at 2pm ET: Have Questions?
Slides available now! Recordings will be available to ACS members after one week.
www.acs.org/acswebinars
1
Contact ACS Webinars ® at acswebinars@acs.org
Have Questions?
“Why am I muted?”
Don’t worry. Everyone is
muted except the presenter
and host. Thank you and
enjoy the show.
•1
•5/11/2016
http://bit.ly/ACSjoin
Find the many benefits of ACS membership!
3
http://bit.ly/ACSjoin 4
•2
•5/11/2016
facebook.com/acswebinars
@acswebinars
®
How has ACS Webinars
benefited you?
6
Be a featured fan on an upcoming webinar! Write to us @ acswebinars@acs.org
•3
•5/11/2016
facebook.com/acswebinars
@acswebinars
youtube.com/acswebinars
8
www.acs.org/acswebinars
•4
•5/11/2016
ChemIDP.org
®
Upcoming ACS Webinars
www.acs.org/acswebinars
10
Contact ACS Webinars ® at acswebinars@acs.org
•5
•5/11/2016
Slides available now! Recordings will be available to ACS members after one week
www.acs.org/acswebinars
Contact ACS Webinars at acswebinars@acs.org 11
UNCLASSIFIED
FORENSIC TOXICOLOGY:
CRACKING THE CASE WITH CHEMISTRY
12 UNCLASSIFIED 05/12/2016
•6
•5/11/2016
UNCLASSIFIED
DISCLAIMER
13 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
OUTLINE
• What is forensic toxicology?
• Pharmacokinetics / pharmacodynamics
• Analytical methods
• Interpretation of results
• Closing thoughts
• Questions
14 UNCLASSIFIED 05/12/2016
•7
•5/11/2016
UNCLASSIFIED
WHAT IS TOXICOLOGY?
• From dictionary.com:
• the science dealing with the effects … of poisons
15 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
COMPLIANCE TESTING
SPECIMENS
• Most often urine
• Sometimes blood, sweat, CHALLENGES
hair, or oral fluid • Fast, cheap testing required
• Setting cutoff levels
• Variable urine density
WHAT IS THE QUESTION? – creatinine normalization
• Using something forbidden? • Conflicting regulations
• Not using something required? • People “beating the test”
16 UNCLASSIFIED 05/12/2016
•8
•5/11/2016
• Urine
• Hair
• Breath
• Blood
• All of the above
17
UNCLASSIFIED
SPECIMENS
• Blood!!
– only way to prove intoxication CHALLENGES
• Breath (presumptive alcohol) • Accurate quantitation critical
• Urine (exposure only) • Specimen handling / storage
– especially for ethanol
18 UNCLASSIFIED 05/12/2016
•9
•5/11/2016
UNCLASSIFIED
DRUG-FACILITATED ASSAULT
SPECIMENS
• Blood ideal, but often CHALLENGES
collected too late
•Extremely low LODs required
• Urine most common
•Huge (& weird) analyte list
• Hair increasingly useful
•Complex pharmacological
interpretation
WHAT IS THE QUESTION? •Educating contributors
• Was a person chemically
incapacitated?
• Possible chemical impairment of
short-term memory?
19 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
POST-MORTEM TOXICOLOGY
SPECIMENS
• Everything but the kitchen sink!
CHALLENGES
• Blood, urine, bile, vitreous
• Huge target analyte list
humour, liver, brain, etc
• Huge range of concentrations
• Putrefaction
• Post-mortem redistribution
WHAT IS THE QUESTION?
• Pharmacological meaning
• Was there a chemical cause
of, or contribution to, death?
• Could insurance claims or
criminal charges be affected?
20 UNCLASSIFIED 05/12/2016
•10
•5/11/2016
UNCLASSIFIED
PHARMACOKINETICS (PK)
• What does the biological system do to the toxicant?
CONCENTRATION
– Adsorption Zero Order Kinetics
2 Compartment Model
(How does it get in?)
– Distribution
(Where does it go?) TIME
– Metabolism
(How does the system try to detoxify it?)
– Excretion
(How does the system get rid of it?)
21 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
PHARMACODYNAMICS (PD)
• What does the toxicant do to the biological system?
• Desired Effects
– Treat disease or symptom
– Antidote to another toxicant
– Change in mental state
• Undesired Effects
– Damage to healthy tissue
– Functional impairment
– Change in mental state
22 UNCLASSIFIED 05/12/2016
•11
•5/11/2016
UNCLASSIFIED
PHARMACOGENOMICS
• How does an individual’s genetic profile affect PK and PD?
23 UNCLASSIFIED 05/12/2016
• Immunoassay
• Gas Chromatography
• Liquid Chromatography
• Gas Chromatography Mass Spectrometry
• Liquid Chromatography Mass Spectrometry
24
•12
•5/11/2016
UNCLASSIFIED
ANALYTICAL TECHNIQUES
• IMMUNOASSAY
• Antibody binding test with colorometric detection
• Fast, cheap, simple, but very little specificity
25 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
MASS SPECTROMETRY
• Only common detection technique providing unambiguous
identification
26 UNCLASSIFIED 05/12/2016
•13
•5/11/2016
UNCLASSIFIED
INTERPRETATION
• What is the question?
• Presence / Absence?
– Absence is usually definitive.
– Mere presence less so.
• Concentration
– Per se limits
– Therapeutic vs. toxic vs. fatal
– Measurement uncertainty
27 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
TOLERANCE
• Pharmacokinetic
– Increased enzyme activity due to toxicant exposure
– Higher dose needed to obtain a given concentration
• Pharmacodynamic
– Altered receptor / messenger activity due to exposure
– Higher concentration needed to obtain a given effect
• Dependence
– Special case of pharmacodynamic tolerance
– Toxicity or impairment from too low a level
28 UNCLASSIFIED 05/12/2016
•14
•5/11/2016
UNCLASSIFIED
DRUG-DRUG INTERACTION
• Pharmacokinetic
– Toxicant competition for available enzymes
– Increased enzyme activity from toxicant exposure
– Effects on renal clearance
• Pharmacodynamic
– (de)Sensitization of receptor systems
– Different receptor systems with the same gross effect
– Additive vs. synergistic vs. antagonistic
• Drug-Food Interactions
– e.g. grapefruit juice
29 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
POST-MORTEM REDISTRIBUTION
• Chemical Potential Gradient
– Biological “pumping” stops
• Gravimetric Gradient
– Fluid redistribution
• Trauma
– Leakage from rupture of the diaphragm, bladder, or GI tract
• Resistant Specimens
– Especially vitreous humour
•15
•5/11/2016
31
UNCLASSIFIED
ETHANOL
• Most Common Toxicant of Forensic Interest
• CNS Depressant
– No single neurotransmitter target
– Depresses higher functions before lower
– Euphoria / excitation at lower doses
– MANY drug-drug interactions
• Per Se Laws
– Based on studies of “average” population
– Back-extrapolation for determination of violation
32 UNCLASSIFIED 05/12/2016
•16
•5/11/2016
UNCLASSIFIED
THC
• Most Common Illicit Toxicant of Forensic Interest
• “Synthetic Cannabinoids”
33 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
OPIOIDS
• Clinically as Analgesics, Antitussives, Anesthetic
Aids
• Opioid Antagonists
– e.g. naloxone; antidote for heroin overdose
34 UNCLASSIFIED 05/12/2016
•17
•5/11/2016
UNCLASSIFIED
HYPNOTIC-SEDATIVES
• CNS Depressants
– Sleep aids, antidepressants, anti-seizure, anesthetic aids
• Barbiturates (direct)
– No longer common (overdose risk and dependence)
• Benzodiazepines (indirect)
– Extremely common prescription drugs
– Complex metabolism and wide range of effects
35 UNCLASSIFIED 05/12/2016
UNCLASSIFIED
STIMULANTS
• Cocaine
– Both enzymatic and non-enzymatic metabolism
– Strong tolerance effects
• Phenethylamines
– Wide range of chemical structures and additional effects
• Pure (almost) stimulant (methamphetamine)
• Decongestant (pseudoephedrine)
• ADHD treatment (methylphenidate)
• Halucinogens (MDMA / “ecstasy”, cathinones / “bath salts”)
36 UNCLASSIFIED 05/12/2016
•18
•5/11/2016
UNCLASSIFIED
CLOSING THOUGHTS
• Forensic toxicology operates at the interface of
pharmacology, and analytical chemistry.
37 UNCLASSIFIED 05/12/2016
Slides available now! Recordings will be available to ACS members after one week
www.acs.org/acswebinars
Contact ACS Webinars at acswebinars@acs.org 38
•19
•5/11/2016
®
Upcoming ACS Webinars
www.acs.org/acswebinars
39
Contact ACS Webinars ® at acswebinars@acs.org
Slides available now! Recordings will be available to ACS members after one week
www.acs.org/acswebinars
Contact ACS Webinars at acswebinars@acs.org 40
•20
•5/11/2016
®
How has ACS Webinars
benefited you?
41
Be a featured fan on an upcoming webinar! Write to us @ acswebinars@acs.org
facebook.com/acswebinars
@acswebinars
youtube.com/acswebinars
•21
•5/11/2016
43
http://bit.ly/ACSjoin
®
ACS Webinars does not endorse any products or
services. The views expressed in this
presentation are those of the presenter and do
not necessarily reflect the views or policies of the
American Chemical Society.
•22
•5/11/2016
®
Upcoming ACS Webinars
www.acs.org/acswebinars
45
Contact ACS Webinars ® at acswebinars@acs.org
•23